Jul 15, 2015 10:47am EDT Immunovaccine's DPX-Survivac Receives Orphan Drug Designation from the FDA for the Treatment of Ovarian Cancer
Jul 08, 2015 7:05am EDT Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax(TM)
Jul 02, 2015 7:05am EDT Immunovaccine Publishes Clinical Results With DPX-Survivac in Combination With an Immune-Modulating Compound
Jun 25, 2015 7:05am EDT Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With Platinum-Sensitive Ovarian Cancer